UniProt ID | CHSS2_HUMAN | |
---|---|---|
UniProt AC | Q8IZ52 | |
Protein Name | Chondroitin sulfate synthase 2 | |
Gene Name | CHPF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 775 | |
Subcellular Localization |
Isoform 1: Golgi apparatus, Golgi stack membrane Single-pass type II membrane protein . Cytoplasm, cytosol . Isoform 3: Cytoplasm, cytosol . Mitochondrion . Isoform 2: Mitochondrion matrix . |
|
Protein Description | Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Isoform 2 may facilitate PRKN transport into the mitochondria. In collaboration with PRKN, isoform 2 may enhance cell viability and protect cells from oxidative stress.. | |
Protein Sequence | MRASLLLSVLRPAGPVAVGISLGFTLSLLSVTWVEEPCGPGPPQPGDSELPPRGNTNAARRPNSVQPGAEREKPGAGEGAGENWEPRVLPYHPAQPGQAAKKAVRTRYISTELGIRQRLLVAVLTSQTTLPTLGVAVNRTLGHRLERVVFLTGARGRRAPPGMAVVTLGEERPIGHLHLALRHLLEQHGDDFDWFFLVPDTTYTEAHGLARLTGHLSLASAAHLYLGRPQDFIGGEPTPGRYCHGGFGVLLSRMLLQQLRPHLEGCRNDIVSARPDEWLGRCILDATGVGCTGDHEGVHYSHLELSPGEPVQEGDPHFRSALTAHPVRDPVHMYQLHKAFARAELERTYQEIQELQWEIQNTSHLAVDGDQAAAWPVGIPAPSRPASRFEVLRWDYFTEQHAFSCADGSPRCPLRGADRADVADVLGTALEELNRRYHPALRLQKQQLVNGYRRFDPARGMEYTLDLQLEALTPQGGRRPLTRRVQLLRPLSRVEILPVPYVTEASRLTVLLPLAAAERDLAPGFLEAFATAALEPGDAAAALTLLLLYEPRQAQRVAHADVFAPVKAHVAELERRFPGARVPWLSVQTAAPSPLRLMDLLSKKHPLDTLFLLAGPDTVLTPDFLNRCRMHAISGWQAFFPMHFQAFHPAVAPPQGPGPPELGRDTGRFDRQAASEACFYNSDYVAARGRLAAASEQEEELLESLDVYELFLHFSSLHVLRAVEPALLQRYRAQTCSARLSEDLYHRCLQSVLEGLGSRTQLAMLLFEQEQGNST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MRASLLLSVLRPAGP CCHHHHHHHHCCCCC | 21.05 | 24719451 | |
47 | Ubiquitination | PGPPQPGDSELPPRG CCCCCCCCCCCCCCC | 45.69 | 22817900 | |
56 | Phosphorylation | ELPPRGNTNAARRPN CCCCCCCCCCCCCCC | 29.11 | 22210691 | |
64 | Phosphorylation | NAARRPNSVQPGAER CCCCCCCCCCCCCCC | 25.47 | 22210691 | |
73 | Ubiquitination | QPGAEREKPGAGEGA CCCCCCCCCCCCCCC | 55.78 | 21906983 | |
91 | Phosphorylation | WEPRVLPYHPAQPGQ CCCCCCCCCCCCCCH | 19.10 | - | |
101 | Ubiquitination | AQPGQAAKKAVRTRY CCCCHHHHHHHHHHH | 44.26 | 21906983 | |
102 | Ubiquitination | QPGQAAKKAVRTRYI CCCHHHHHHHHHHHH | 47.60 | 22817900 | |
110 | Phosphorylation | AVRTRYISTELGIRQ HHHHHHHHHHHHHHH | 13.59 | 23186163 | |
111 | Phosphorylation | VRTRYISTELGIRQR HHHHHHHHHHHHHHH | 26.18 | 23186163 | |
126 | Phosphorylation | LLVAVLTSQTTLPTL HHHHHHHCCCCCCCH | 22.74 | 17525332 | |
129 | Phosphorylation | AVLTSQTTLPTLGVA HHHHCCCCCCCHHHH | 24.09 | 17525332 | |
138 | N-linked_Glycosylation | PTLGVAVNRTLGHRL CCHHHHHHHHHHHHC | 22.83 | UniProtKB CARBOHYD | |
154 | Ubiquitination | RVVFLTGARGRRAPP EEEEEECCCCCCCCC | 12.91 | 21963094 | |
176 | Ubiquitination | GEERPIGHLHLALRH CCCCCHHHHHHHHHH | 15.70 | 22817900 | |
276 | Ubiquitination | DIVSARPDEWLGRCI CHHHCCCCHHHHCHH | 54.90 | 21963094 | |
283 | Ubiquitination | DEWLGRCILDATGVG CHHHHCHHHHCCCCC | 3.62 | 21963094 | |
312 | Ubiquitination | LSPGEPVQEGDPHFR ECCCCCCCCCCCCHH | 60.72 | 22817900 | |
313 | Ubiquitination | SPGEPVQEGDPHFRS CCCCCCCCCCCCHHH | 66.84 | 22817900 | |
323 | Phosphorylation | PHFRSALTAHPVRDP CCHHHHHHCCCCCCC | 23.72 | - | |
338 | Ubiquitination | VHMYQLHKAFARAEL CHHHHHHHHHHHHHH | 54.51 | 21906983 | |
361 | N-linked_Glycosylation | ELQWEIQNTSHLAVD HHHHHHHCCCCEEEC | 49.57 | UniProtKB CARBOHYD | |
405 | Ubiquitination | TEQHAFSCADGSPRC CCCCEEECCCCCCCC | 3.02 | 21963094 | |
441 | Ubiquitination | NRRYHPALRLQKQQL HHHHCHHHHHHHHHH | 7.09 | 22817900 | |
442 | Ubiquitination | RRYHPALRLQKQQLV HHHCHHHHHHHHHHH | 36.86 | 22817900 | |
445 | Ubiquitination | HPALRLQKQQLVNGY CHHHHHHHHHHHCCC | 44.60 | 21906983 | |
452 | Phosphorylation | KQQLVNGYRRFDPAR HHHHHCCCCCCCCCC | 8.07 | - | |
492 | Phosphorylation | VQLLRPLSRVEILPV HHHCCCCCCCEEECC | 36.64 | 26434776 | |
567 | Ubiquitination | ADVFAPVKAHVAELE CCCHHHHHHHHHHHH | 31.54 | 21906983 | |
603 | Ubiquitination | RLMDLLSKKHPLDTL HHHHHHCCCCCCCEE | 55.88 | 21906983 | |
604 | Ubiquitination | LMDLLSKKHPLDTLF HHHHHCCCCCCCEEE | 47.26 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHSS2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHSS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHSS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PRKN_HUMAN | PARK2 | physical | 22082830 | |
TRIPB_HUMAN | TRIP11 | physical | 27173435 | |
MED4_HUMAN | MED4 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND THR-129, ANDMASS SPECTROMETRY. |